ECHS1 and Leigh syndrome: Urine cysteine/cysteamine conjugates with acrylyl-CoA are routinely used to diagnose Leigh syndrome where the conversion of acrylyl-CoA to 3-hydroxypropionyl-CoA is inhibited due to a deficiency in the short chain enoyl-CoA hydratase (ECHS1) activity (40).